Release date: 4 June 2019
Promoter – Financial Intermediary
KONINKLIJKE PHILIPS NVLocation
Description
The project consists of the financing of Philips' expenditure on research and development in the area of healthcare technology.
Objectives
The project concerns the promoter's Research, Development and Innovation (RDI) activities related to an innovative portfolio of products in healthcare informatics, diagnosis and treatment and personal health.
Sector(s)
- Industry - Manufacturing
Proposed EIB finance (Approximate amount)
EUR 200 million
Total cost (Approximate amount)
EUR 404 million
Environmental aspects
The project concerns investments in Research and Development (R&D) that are expected to be carried out in already authorised existing facilities, which would therefore not require an Environmental Impact Assessment (EIA) under Directive 2011/92/EU. Full environmental details will be verified during the appraisal.
Procurement
The promoter is a private company not operating in the utilities sector and is thus not covered by EU Directives on procurement.
Status
Signed - 22/02/2018
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).